Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma. Article uri icon

Overview

authors

  • Pro, Barbara
  • Horwitz, Steven Michael
  • Prince, H Miles
  • Foss, Francine M
  • Sokol, Lubomir
  • Greenwood, Matthew
  • Caballero, Dolores
  • Morschhauser, Franck
  • Wilhelm, Martin
  • Iyer, Swaminathan Padmanabhan
  • Shustov, Andrei R
  • Wolfson, Julie
  • Balser, Barbara E
  • Coiffier, Bertrand

publication date

  • July 12, 2016

Research

keywords

  • Depsipeptides
  • Lymphoma, T-Cell, Peripheral

Identity

PubMed Central ID

  • PMC5763404

Scopus Document Identifier

  • 84994087158

Digital Object Identifier (DOI)

  • 10.1002/hon.2320

PubMed ID

  • 27402335

Additional Document Info

volume

  • 35

issue

  • 4